Orkin, C, Squires, K E, Molina, J-M, Sax, P E, Wong, W-W, Sussmann, O, Kaplan, R, Rodgers, A, Nguyen, B-Y, Hwang, C, Hanna, G J, Lin, G, Lupinacci, L, Sklar, P, Kumar, S, Xu, X, Martin, E A, DRIVE-AHEAD Study Group & Nielsen, H I 2019, ' Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection : Week 48 Results of the DRIVE-AHEAD Trial ', Clinical Infectious Diseases, vol. 68, no. 4, pp. 535-544 . https://doi.org/10.1093/cid/ciy540 Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America